Loco-Regional Treatment of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapies

Publisher： Karger

E-ISSN： 1423-0232|78|1|107-112

ISSN： 0030-2414

Source： Oncology, Vol.78, Iss.1, 2010-07, pp. : 107-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

From Molecular Biology to Targeted Therapies for Hepatocellular Carcinoma: The Future Is Now

By  

Oncology, Vol. 72, Iss. 1, 2007-12 ,pp. : 30-44

Karger

Access to resources Recommend Favorite

Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 6, 2010-06 ,pp. : 1023-1025

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcomes of surgical resection and loco‐regional therapy in patients with stage 3A hepatocellular carcinoma: a retrospective review from the national cancer database

By  

HPB, Vol. 17, Iss. 11, 2015-11 ,pp. : 964-968

John Wiley & Sons Inc

Access to resources Recommend Favorite

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E1-E11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Pathogenesis and Targeted Therapy of Hepatocellular Carcinoma

By  

Oncology Research and Treatment, Vol. 31, Iss. 10, 2008-09 ,pp. : 550-555

Karger

Access to resources Recommend Favorite